Antibiotic use is a negative predictor of the efficacy and toxicity of epidermal growth factor receptor-targeted therapy in advanced non-small cell lung cancer.

Liu, Kejun; Zhang, Weiwei; Tan, Qinquan; Jiang, Guanming; Jia, Jun

Liu, Kejun; Zhang, Weiwei; Tan, Qinquan; Jiang, Guanming; Jia, Jun.

Afiliação

Liu K; Department of Oncology, Dongguan Institute for Clinical Cancer Research, Dongguan People's Hospital, Southern Medical University, Dongguan, Guangdong 523059, P.R. China.
Zhang W; Department of Oncology, The Fifth People's Hospital of Chengdu, Chengdu, Sichuan 611130, P.R. China.
Tan Q; Department of Oncology, Dongguan Institute for Clinical Cancer Research, Dongguan People's Hospital, Southern Medical University, Dongguan, Guangdong 523059, P.R. China.
Jiang G; Department of Oncology, Dongguan Institute for Clinical Cancer Research, Dongguan People's Hospital, Southern Medical University, Dongguan, Guangdong 523059, P.R. China.
Jia J; Department of Oncology, Dongguan Institute for Clinical Cancer Research, Dongguan People's Hospital, Southern Medical University, Dongguan, Guangdong 523059, P.R. China.

Oncol Lett ; 18(3): 2677-2683, 2019 Sep.

Article em En | MEDLINE | ID: mdl-31404289

Palavras-chave

antibiotics; first-line therapy; non-small cell lung cancer; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google